STAT March 14, 2019
Jennifer Bright, Mark Linthicum

In the ongoing debate about value in health care, the narrative in the media, political campaigns, and congressional hearings has consistently focused on the relatively narrow issue of drug pricing.

We are squandering time and resources trying to find a neat answer to “what is value?” by focusing on the cost of drugs without tackling other hard questions at the heart of measuring value across health care interventions.

Determining the value of health care requires understanding both its benefits and its costs — a complex undertaking that is sadly oversimplified in the public debate. Tellingly, Novartis CEO Vas Narasimhan said recently that one of the biggest things he has learned in the past year was how little understanding there is among the public about the...

Livongo
2019-03-14T23:44:22-04:00